Optimal end point of FR167653 administration and expression of interleukin-8 messenger RNA on extended liver resection with ischemia in dogs
1
1
No competing interests declared.
2
2
Fujisawa Pharmaceutical Co Ltd provided Gunma University with research funds.
Titel:
Optimal end point of FR167653 administration and expression of interleukin-8 messenger RNA on extended liver resection with ischemia in dogs
1
1
No competing interests declared.
2
2
Fujisawa Pharmaceutical Co Ltd provided Gunma University with research funds.